Metraipolis › archive › dc_ad61fea798d9

NeoPrecis: enhancing immunotherapy response prediction through integration of qualified immunogenicity and clonality-aware neoantigen landscapes — Europe PMC PMID:41577704

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41577704
DOI
10.1038/s41467-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-06T13:04:56.660Z
SHA-256 of the archived text
6c903fe1430f918c804c811709063a51aec8e3db38f62f7ec92fd5e5b04934a9
Stable URL of this page
https://metraipolis.com/documento/dc_ad61fea798d9

How to cite

NeoPrecis: enhancing immunotherapy response prediction through integration of qualified immunogenicity and clonality-aware neoantigen landscapes — Europe PMC PMID:41577704 — Europe PMC (en), https://europepmc.org/article/MED/41577704 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad61fea798d9 (Metraipolis archive dc_ad61fea798d9, sha256 6c903fe1430f918c804c811709063a51aec8e3db38f62f7ec92fd5e5b04934a9)
BibTeX
@misc{dcad61fea798d9,
  title = {NeoPrecis: enhancing immunotherapy response prediction through integration of qualified immunogenicity and clonality-aware neoantigen landscapes — Europe PMC PMID:41577704},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41577704},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad61fea798d9; sha256 6c903fe1430f918c804c811709063a51aec8e3db38f62f7ec92fd5e5b04934a9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41577704. Agents can read the archived copy with the MCP tool read_document.